A subcutaneous injection that can administer an immunotherapy in 1–2 minutes using domestic technology has been developed and approved in the United States. Immunotherapies are usually given ...
Testosterone therapy can help men with low hormone levels, but experts warn of serious risks including stroke, prostate ...
KEYTRUDA QLEX is the first and only subcutaneously administered immune checkpoint inhibitor that can be given by a health care provider in as little as one minute RAHWAY, N.J., September 19, ...
Researchers sought to determine whether subcutaneous isatuximab would be an effective treatment for patients with RRMM.
The Chosun Ilbo on MSN
Keytruda Subcutaneous Formulation Receives FDA Approval
The first immune checkpoint inhibitor that can be administered via a subcutaneous injection in just 1 to 2 minutes has emerged. Alteogen announced on the 20th that its partner, U.S.-based Merck (MSD), ...
KEYTRUDA QLEX is the first and only subcutaneously administered immune checkpoint inhibitor that can be given by a health care provider in as little as one minute ...
Testosterone gel can remain on the skin after application, creating a small but real risk for transfer through close contact ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA QLEX™ (pembrolizumab and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback